Overview

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of neoadjuvant electrochemotherapy on locally advanced rectal cancer (UICC II-III) in an intended curative clinical setting, using an endoscopic electroporation device (EndoVE).
Phase:
Phase 2
Details
Lead Sponsor:
Zealand University Hospital
Collaborators:
Herlev Hospital
Rigshospitalet, Denmark
Treatments:
Bleomycin